Gross margin increased by 0.06 points
Gross margin moved +0.06 percentage points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved +0.06 percentage points from the comparable as-filed period.
Stock-based compensation changed -1.1% from the comparable as-filed period.
Capital expenditure changed +474.0% from the comparable as-filed period.
Cash & equivalents changed +47.7% from the comparable as-filed period.
Free-cash-flow proxy changed -56.8% from the comparable as-filed period.
Net income changed +26.6% from the comparable as-filed period.
Operating cash flow changed -44.8% from the comparable as-filed period.
Capex / revenue moved +2.65 percentage points from the comparable as-filed period.
Gross profit changed +13.0% from the comparable as-filed period.
Operating income changed +16.6% from the comparable as-filed period.
Research & development changed +11.8% from the comparable as-filed period.
Revenue changed +12.9% from the comparable as-filed period.
Inventory changed -5.8% from the comparable as-filed period.
Operating margin moved +0.59 percentage points from the comparable as-filed period.
Selling, general & administrative changed +9.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.